The Trump administration finally has one good idea to lower drug prices
From the article:
Right now, in the above circumstances and when there isn’t an actual drug shortage, “we don’t have a good policy solution,” Scott Gottlieb, the FDA commissioner, told me Thursday in a brief phone interview.
The policy would be applied in limited circumstances — only for generic drugs and only temporarily, it appears — and could therefore have only a limited effect, but experts still say it’s a good idea.
“I think this is a smart move for the administration,” Rachel Sachs, a law professor at Washington University in St. Louis, who has generally been unimpressed by what the Trump administration has proposed on drug prices, told me.
Read more here!fda health care finance health care reform health law policy pharmaceuticals rachel sachs